Fast Facts

• Benzodiazepine addiction can happen with illicit use or prescribed use. Risk rises with longer use, higher doses, and mixing with other drugs. NIDA
• Benzodiazepine dependence can develop even when a person follows their prescription. The body can adapt over time, leading to tolerance and withdrawal. NCBI Bookshelf
• It most often affects adults who take benzodiazepines for anxiety, panic, insomnia, or seizure disorders, especially older adults and people with other substance use problems. CDC
• Warning signs include needing more to get the same effect, running out early, taking doses not prescribed, strong cravings, and trouble with memory, mood, work, or relationships.
• Stopping benzodiazepines suddenly can be dangerous. Withdrawal may cause severe anxiety, tremor, or seizures, so tapering should be guided by a clinician. SAMHSA
• A professional evaluation is appropriate if use feels hard to control, daily life is affected, or withdrawal symptoms appear between doses.

Clinical definition

Benzodiazepine addiction is a pattern of compulsive benzodiazepine use despite harm. In clinical practice, this is usually diagnosed as benzodiazepine use disorder under the DSM-5-TR. The diagnosis is based on symptoms such as loss of control, cravings, risky use, and continued use even when it causes problems.

Addiction vs. dependence vs. misuse

• Addiction: ongoing, hard-to-control use that keeps happening despite harm.
• Physical dependence: the body adapts to the medicine, so stopping can cause withdrawal. This can happen even when the drug is taken exactly as prescribed, according to NIDA.
• Misuse: taking benzodiazepines in a way other than prescribed, such as higher doses or use without a prescription.

Common benzodiazepines

Common prescribed benzodiazepines include alprazolam, lorazepam, clonazepam, diazepam, temazepam, and triazolam. Not everyone who takes these medicines develops addiction, but long-term or nonmedical use can raise risk, as noted by SAMHSA.

Benzodiazepines slow the brain by boosting GABA-A receptor activity.

Benzodiazepines increase the effect of GABA, a chemical that calms the central nervous system. They bind to the GABA-A receptor and make nerve cells fire less. This causes sedation, slower thinking, and muscle relaxation.

Tolerance and dependence can develop as the brain adapts.

With repeated use, the brain becomes less responsive to the drug. This can lead to tolerance, so a person may need more to feel the same effect. Over time, the brain starts to rely on the drug, which drives physical dependence.

Rebound symptoms can reinforce continued use.

When the drug wears off, the calming effect drops fast. That can trigger rebound symptoms like worse anxiety, insomnia, restlessness, or panic. This pattern can push repeated use because the next dose brings quick relief.

Short-acting and long-acting benzodiazepines can feel different.

• Short-acting drugs wear off faster, so rebound symptoms may appear sooner and feel more intense.
• Long-acting drugs stay in the body longer, which can delay withdrawal but prolong sedation and drug buildup.

It often starts with symptom relief.

Anxiety disorders, insomnia, and high stress can make benzodiazepines feel helpful fast. Risk rises when a prescription lasts longer than intended, doses go up over time, or the medication is taken more often than prescribed. FDA boxed warnings note misuse, dependence, and withdrawal risks.

Mental health and trauma can increase vulnerability.

People with trauma, depression, or other co-occurring disorders may use benzodiazepines to numb distress or sleep. That coping pattern can become hard to stop, especially when symptoms return between doses.

Polydrug use raises the risk.

• Using benzodiazepines with alcohol, opioids, or other drugs increases harm and can reinforce repeated use. See NIDA.
• A past or current substance use disorder makes problematic use more likely.
• Longer duration of use is a major risk factor; many guidelines advise short-term use when possible.

Common signs of benzodiazepine addiction

Benzodiazepine misuse often shows up in behavior, mood, and daily function. SAMHSA and the DSM-5-TR note patterns like loss of control, continued use despite harm, and trouble meeting responsibilities.

• Behavioral warning signs: taking more than prescribed, running out early, doctor shopping, hiding use
• Physical signs: sedation, drowsiness, slurred speech, confusion, coordination problems, blackouts, memory problems
• Psychological symptoms: anxiety between doses, irritability, mood swings, poor focus
• Functional impairment: unsafe driving, falls, work or school problems, relationship conflict

Withdrawal and health risks

NIDA warns that benzodiazepine withdrawal can be dangerous, especially after regular or high-dose use. Symptoms may include rebound anxiety, insomnia, tremor, sweating, confusion, and seizures.

• Short-term risks: overdose risk is higher when mixed with opioids or alcohol, severe sedation, accidents, and blackouts
• Long-term risks: ongoing memory problems, dependence, worse mood symptoms, and greater injury risk from falls
• Signs that may suggest a use disorder: strong cravings, failed efforts to cut down, spending a lot of time getting or using pills, and withdrawal when use stops

Prescribing and prevalence

NIDA, CDC, and national prescribing data show benzodiazepines are still widely used, though prescribing has changed in recent years because of safety concerns. Research studies in epidemiology find that misuse is more common in adults who also use opioids, alcohol, or other sedating drugs.

Who faces higher risk

• People taking benzodiazepines for long periods
• Older adults, who face higher risks of falls, memory problems, and sedation
• People with anxiety disorders, insomnia, chronic pain, or substance use disorders
• People using opioids at the same time

Harms and clinical consensus

FDA boxed warnings and SAMHSA guidance warn that combining benzodiazepines with opioids can raise overdose risk. Clinical consensus says long-term use should be limited when possible because risks increase over time.

Limits of the evidence

Some research studies rely on self-report, insurance claims, or older prescribing data. That means the evidence is strong on safety risks, but less precise on how many people develop severe benzodiazepine addiction.

Seek an assessment early

Get a professional assessment if benzodiazepine use is getting hard to control, causing withdrawal, or affecting work, school, or relationships. A clinician can review your use, other substances, mental health, and medical needs. The SAMHSA National Helpline can help you find care.

Do not stop benzodiazepines suddenly

Abrupt stopping can cause severe withdrawal, including seizures. The NIDA and ASAM recommend medical detox or a supervised tapering plan when needed.

Treatment options

• Medical detox: 24/7 monitoring for withdrawal and safety.
• Inpatient treatment or residential treatment: structured daily care.
• Partial hospitalization program or intensive outpatient program: strong support with more flexibility.
• Outpatient treatment: ongoing visits for tapering, therapy, and follow-up.

What treatment includes

Most plans include therapy, relapse prevention, and treatment for anxiety, sleep problems, or other substance use. During intake, expect questions about medications, health history, symptoms, and home support. Family can help by attending visits, supporting the tapering plan, and avoiding pressure to quit too fast.